Edgestream Partners L.P. Reduces Stock Position in Acadia Healthcare Company, Inc. $ACHC

Edgestream Partners L.P. reduced its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 67.8% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 20,119 shares of the company’s stock after selling 42,454 shares during the period. Edgestream Partners L.P.’s holdings in Acadia Healthcare were worth $471,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in ACHC. EverSource Wealth Advisors LLC increased its position in shares of Acadia Healthcare by 54.8% during the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock valued at $32,000 after buying an additional 497 shares during the period. Wells Fargo & Company MN increased its stake in Acadia Healthcare by 208.9% in the 4th quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock worth $32,000 after acquiring an additional 1,510 shares during the last quarter. Bayforest Capital Ltd bought a new stake in shares of Acadia Healthcare during the 4th quarter valued at about $52,000. Caitong International Asset Management Co. Ltd increased its position in shares of Acadia Healthcare by 4,264.8% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 5,325 shares of the company’s stock worth $76,000 after purchasing an additional 5,203 shares during the last quarter. Finally, Parallel Advisors LLC raised its stake in Acadia Healthcare by 857.8% in the first quarter. Parallel Advisors LLC now owns 6,858 shares of the company’s stock valued at $160,000 after purchasing an additional 6,142 shares in the last quarter.

Analyst Upgrades and Downgrades

ACHC has been the topic of a number of research reports. KeyCorp raised their price target on Acadia Healthcare from $30.00 to $40.00 and gave the company an “overweight” rating in a research report on Tuesday, July 14th. Raymond James Financial upgraded Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 target price for the company in a research report on Monday, May 4th. Guggenheim upped their price target on shares of Acadia Healthcare from $38.00 to $39.00 and gave the company a “buy” rating in a research report on Thursday, July 30th. TD Cowen raised their target price on shares of Acadia Healthcare from $30.00 to $36.00 and gave the stock a “buy” rating in a report on Tuesday, July 14th. Finally, UBS Group upped their price target on shares of Acadia Healthcare from $31.00 to $39.00 and gave the company a “buy” rating in a report on Thursday, July 9th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have issued a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $29.85.

Acadia Healthcare Stock Up 1.8%

Acadia Healthcare stock opened at $32.24 on Thursday. The stock has a fifty day moving average of $28.71 and a 200 day moving average of $24.22. Acadia Healthcare Company, Inc. has a one year low of $11.43 and a one year high of $35.83. The company has a debt-to-equity ratio of 1.20, a quick ratio of 1.57 and a current ratio of 1.57. The stock has a market cap of $3.00 billion, a PE ratio of -2.59, a price-to-earnings-growth ratio of 10.28 and a beta of 0.64.

Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Tuesday, July 28th. The company reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.35 by $0.03. The company had revenue of $865.84 million during the quarter, compared to analyst estimates of $844.19 million. Acadia Healthcare had a negative net margin of 33.44% and a positive return on equity of 6.19%. The firm’s quarterly revenue was down .4% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.83 EPS. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. As a group, sell-side analysts predict that Acadia Healthcare Company, Inc. will post 1.54 EPS for the current year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.